Prostaglandins and Leukotrienes in Gastrointestinal Diseases
In OCtober 1986, recognized authorities from a variety of disciplines met in Lisbon, Portugal, to review recent knowledge on eicosanoids - i. e., prostaglandins, throm boxane A , and leukotrienes - and their role in gastrointestinal diseases. 2 Briefly, in the stomach endogenous as well as exogenou...
| Other Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Berlin, Heidelberg
Springer Berlin Heidelberg
1988, 1988
|
| Edition: | 1st ed. 1988 |
| Subjects: | |
| Online Access: | |
| Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- Biology and Pharmacology of Prostaglandins and Leukotrienes
- Biosynthesis and Metabolism of Prostaglandins and Thromboxanes. Quantitative Determination in Biological Material
- Discussion
- Involvement of the Eicosanoids, Thromboxane A2 and Leukotriene C4 in Gastric Mucosal Damage
- Discussion
- Microvascular Injury and the Role of Leukotrienes and Prostaglandins in Acute Mucosal Damage and Protection
- Discussion
- Inhibition of Prostaglandin Synthesis and Proliferation of the Gastric Mucosa
- Discussion
- Role of Prostaglandins in Intestinal Fluid Secretion
- Discussion
- Novel Leukotriene D4 Receptor Antagonists and 5-Lipoxygenase Inhibitors: Implications in Human Disease
- Discussion
- Protective Effects on the Gastrointestinal Mucosa. New Aspects of the Last two Years
- “Aggressive” and “Protective” Factors in the Pathogenesis of Peptic Ulcer Disease
- Discussion
- Heartburn and Mucosal Barrier Weakness
- Discussion
- Discussion
- Colitis and Non-Steroidal Anti-Inflammatory Drugs
- Discussion
- Therapeutic Role for Prostaglandins in Ulcerative Colitis?
- Discussion
- Inflammatory Bowel Disease: Treatment Modalities and Mucosal Prostaglandin/Leukotriene Formation
- Discussion
- Prostaglandins: Their Potential Therapeutic Value in the Upper Gastrointestinal Tract
- The Natural History of Ulcer Disease and its Impact upon Therapeutic Options and Assessment of Drug Safety
- Benefits and Risks of Long-Term Medical Therapy with Histamine H2-Receptor Antagonists in Ulcer Disease — A Physician’s View
- Benefits and Risks of Long-Term Medical Therapy with Histamine H2-Receptor Antagonists in Ulcer Disease: A Surgeon’s View
- The Surgical Approach to Ulcer Disease and its Complications — Hasthere been a Change in the Last Decade?
- The Efficacy of Prostaglandins in the Prevention of Stress Lesions in the Critically I11 Patient
- Discussion Following this Section
- Clinical Aspects of the Protective Effects of Prostaglandins on Non-Steroidal Anti-Inflammatory Drug-Associated Mucosal Injury
- Discussion
- Prostaglandins and Leukotrienes in Gastrointestinal Diseases — Present Clinical Role
- Gastrointestinal Microbleeding and Ulcerogenic Drugs: Prevention by Co-Administration of Prostaglandins
- Discussion
- Exogenous Prostaglandins and Their Analogues in Gastric Ulcer Therapy
- Exogenous Prostaglandins and Their Analogues in Duodenal Ulcer Therapy
- Discussion
- Clinical Safety of Antiulcer Prostaglandins: An Overview
- Discussion
- Ulcer Healing Drugs and Endogenous Prostaglandins: Carbenoxolone, Antacids, Sucralfate, Bismuth, and H2-Receptor Antagonists
- Discussion
- Smoking and Ulcer Healing — Role for Prostaglandins?
- Discussion
- Ulcer Healing by Prostaglandins — Due to Decreased Acidity or Enhanced Mucosal Defense?
- Discussion
- Diarrheagenic Syndromes Sensitive to Prostaglandin Synthetase Inhibitors
- The Functional Role of Prostanoids in the Gastroduodenal Mucosa
- Role of Leukotrienes in Gastric Mucosal Damage and Protection
- Discussion
- Effect of Prostaglandins on the Motility of the Digestive Tract
- Discussion
- Gastroduodenal Bicarbonate Secretion in Mucosal Protection
- Discussion
- Prostaglandins and Cellular Restitution — Physiological and Pathological Implications
- Discussion
- Prostanoid Inhibition of Acid Secretion — Cellular Mechanisms in Canine Fundic Mucosa
- Discussion
- The Protective Effects of Prostaglandins on the Gastric Microvasculature
- Non-Steroidal Anti-Inflammatory Drugs and Peptic Ulcer
- Discussion
- Mechanism of Injury to Gastric Mucosa by Non-Steroidal Anti-Inflammatory Drugs and the Protective Role of Prostaglandins
- Discussion
- Can Nonantisecretory Doses of Prostaglandins Prevent Mucosal Damage inNon-Steroidal Anti-Inflammatory Drugs?